Nitric oxide attenuates beryllium-induced IFNγ responses in chronic beryllium disease: Evidence for mechanisms independent of IL-18

Clinical Immunology

Volumn 103, Issue 2, 2002, Pages 169-175

  Barna, Barbara P ^a   Dweik, Raed A ^a   Farver, Carol F ^a   Culver, Daniel ^a   Yen Lieberman, Belinda ^a   Thomassen, Mary Jane ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Beryllium; Bronchoalveolar lavage cells; Cytokine; Granuloma; IFN ; IL 18; Lung; Nitric oxide

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; NITRIC OXIDE;

ANTIBODY DETECTION; ARTICLE; BERYLLIOSIS; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; HUMAN; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; LUNG LAVAGE; PRIORITY JOURNAL; SENSITIZATION; SIGNAL TRANSDUCTION;

EID: 0036260701     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5211     Document Type: Article

References (35)

1. Beryllium disease
2. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant
3. A study of the immunologic aspects of chronic berylliosis
4. Screening blood test identifies subclinical beryllium disease
5. Bronchoalveolar lavage in patient with chronic berylliosis: Evidence for hypersensitivity pneumonitis
6. Proliferative response of bronchoalveolar lymphocytes to beryllium
7. Epidemiology of beryllium sensitization and disease in nuclear workers
8. Beryllium induces IL-2 and IFN-y in berylliosis
9. Interleukin- 18 regulates both Th1 and Th2 responses
10. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-y production
11. Functional reconstitution and regulation of IL-18 activity by the IL- 18RB chain
12. Cutting edge: IL-18-transgenic mice: In vivo evidence of a broad role for IL-18 in modulating immune function
13. A mechanism underlying synergy between IL-12 and IFN-y-inducing factor in enhanced production of IFN-y
14. Cutting edge: IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-y promoter in primary CD4+ T lymphocytes
15. High levels of nitric oxide (NO) in exhaled breath in patients with chronic beryllium disease
16. Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide
17. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells
18. Continuous nitric Oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium
19. Interferon-gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators
20. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells
21. Nitric oxide prevents IL-1B and IFN-y-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1b converting enzyme)
22. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages
23. Nitric oxide blocks nuclear factor-κB activation in alveolar macrophages
24. Activation of interferon-y inducing factor mediated by interleukin-1B converting enzyme
25. IL-1B-converting enzyme (ICE) is present and functional in human alveolar macrophages: Macrophage IL-1B release limitation is ICE independent
26. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis
27. Interleukin 18: Tipping the balance towards a T helper cell 1 response
28. A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease
29. IFN-y up-regulates IL-18 gene expression via IFN consensus sequence-binding protein and activator protein-1 elements in macrophages
30. HLA-DPB1 Glutamate 69: A genetic marker of beryllium disease
31. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis
32. IL-12 and IL-18 are increased and stimulate IFN-γ production in sarcoid lungs
33. Nitric oxide and airway disease
34. Nitric oxide and airway reactivity
35. Nitric oxide selectively decreases interferon-y expression by activated human T lymphocytes via a cGMP-independent mechanism